2026 AAD Annual Meeting: Exhibitor Product Theaters
Discover the latest industry insights at the 2026 Annual Meeting through engaging educational and product-focused sessions. These presentations give exhibiting companies a platform to unveil groundbreaking research, showcase product innovations, perform live demonstrations, and highlight their newest offerings.
These sessions are solely promotional and are not eligible for CME credit.
Session schedule
Friday, March 27, 2026 | Theater 1 |
|---|
10:30 a.m. - 11:15 a.m.
Presented by: Skyline Dx
Latest Advances in Gene Expression Profiling (GEP) and GEP Guideline Updates for Cutaneous Melanoma
Review the development, validation, and clinical applications of the CP-GEP test in melanoma, featuring data from the largest prospective, multi-center blinded Melanoma GEP Study: MERLIN-001 published in JAMA Surgery Q4 2025 and recent Guideline Updates regarding the Merlin CP-GEP Test.
12:00 p.m. - 12:45 p.m
Presented by: CP Skin Health
Innovations in Acne and Pigment Care: Therapeutic Photoprotection and the Synergy of Microneedling with Controlled Chemical Resurfacing
Explore new clinical data on blemish-correcting photoprotection and discover why combining microneedling with controlled chemical resurfacing yields superior pigment correction and skin clarity.
1:30 p.m. - 2:15 p.m.
Presented by: Lumenis
Ablative Resurfacing Masterclass: Clinical Pearls for Superior Outcomes
Case-based symposium with leading dermatologists on ablative resurfacing, addressing patient selection, technique optimization, and real-time endpoints. Acquire practical protocols to enhance outcomes, recovery, and patient experience.
3:00 p.m. - 3:45 p.m.
Presented by: CLASSYS
Beyond Traditional RF: Safety and Efficacy of Everesse’s Innovative Water-cooling System
This session examines how Everesse’s water-cooling RF system overcomes limitations of traditional RF, delivering controlled dermal heating with improved safety, consistency, and clinically validated efficacy.
Saturday, March 28, 2026 | Theater 1 |
|---|
10:30 a.m. - 11:15 a.m.
Presented by: AbbVie
Sailing into Clear Horizons
A Review of SKYRIZI (risankizumab-rzaa) Clinical Efficacy and Safety Data.
12:00 p.m. - 12:45 p.m.
Presented by: Eli Lilly
Explore EBGLYSS®(lebrikizumab-lbkz)
Join us for "Explore EBGLYSS® (lebrikizumab-lbkz), an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and how to get patients started on EBGLYSS.
1:30 p.m. - 2:15 p.m.
Presented by: Actera
Drug-Like Cosmetics: How prodrug actives are game-changers for next-gen skincare
New precursor compounds, activated by skin enzymes to provide drug-like efficacy, are changing how practitioners and product developers create skincare. Attendees will learn how prodrug cosmetics improve efficacy, access, and customization. Presented by board-certified dermatologist, Dr. Mamina Turegano.
3:00 p.m. - 3:45 p.m.
Presented by: Novartis Pharmaceuticals Corporation
Now Approved: A new path forward with RHAPSIDO® (remibrutinib)
This program will provide an insightful view of RHAPSIDO®, including mechanism of action with RHAPSIDO; demonstrated efficacy and safety data; and getting patients started on RHAPSIDO.
Sunday, March 29, 2026 | Theater 1 |
|---|
12:00 p.m. - 12:45 p.m.
Presented by: Eli Lilly
A Product Theater for Taltz® (ixekizumab) and Zepbound® (tirzepatide) Injection including an Affordability Program for Eligible Taltz Patients Prescribed Zepbound.
Join us for this Lilly event! Please see Full Prescribing Information for Zepbound including Boxed Warning and Medication Guide at the product theater or on www.zepbound.lilly.com
1:30 p.m. - 2:15 p.m.
Presented by: Doximity
AI for Dermatologists: Optimizing Clinical Workflows with Doximity GPT
Explore how DoxGPT saves time with secure, HIPAA-compliant AI—delivering evidence-based answers, journal and drug references, admin automation, CME credit, and live demos of real clinical use cases.
Friday, March 27, 2026 | Theater 2 |
|---|
11:15 a.m. - 12:00 p.m.
Presented by: DISC Medicine
Getting to the core of EPP and XLP: Understanding, diagnosing, and managing erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP)
An educational program providing an overview of Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), the role of PPIX, and how PPIX accumulation drives the multisystemic burden of disease.
12:45 p.m. - 1:30 p.m.
Presented by: Eli Lilly
Long-Term Disease Stability with Antibody Monotherapies in Moderate-to-Severe Atopic Dermatitis
Gain insights into AD cytokine-driven pathophysiology, antibody monotherapy mechanisms of action, and efficacy/safety data supporting durable disease control across diverse patient populations.
2:15 p.m. - 3:00 p.m.
Presented by: AbbVie
Raising the Bar
Exploring higher-level endpoints from a head-to-head study in the treatment of moderate to severe atopic dermatitis.
3:45 p.m. - 4:30 p.m.
Presented by: Pelthos Therapeutics
Challenging the Watch‑and‑Wait Paradigm: Introducing Zelsuvmi™ (berdazimer) topical gel, 10.3%
Join us for an engaging presentation on challenging the traditional watch-and-wait thinking by examining unmet needs, patient burden, and emerging topical science that may influence how clinicians approach management decisions.
Saturday, March 28, 2026 | Theater 2 |
|---|
11:15 a.m. - 12:00 p.m.
Presented by: RoC Skincare
Evaluating the Role of RoC Retinol in Skin Longevity
This session reviews RoC’s history in retinol research and presents findings from a new clinical study evaluating retinol use and outcomes relevant to skin longevity.
2:15 p.m. - 3:00 p.m.
Presented by: Codex Labs Corp
Clinical Evaluation of a Novel Topical Gel to Support Post-Laser Skin Recovery
Clinical outcomes of a post-procedural topical gel after laser and radiofrequency microneedling, assessing erythema resolution, barrier function restoration, downtime reduction, safety, and patient-reported comfort.
3:45 p.m. - 4:30 p.m.
Presented by: ISDIN
Targeted Cellular Repair in Next-Generation Photoprotection
"Explore how next-generation photoprotection is evolving beyond UV filters to address the biological complexity of photoinduced damage.
- Chairman: Henry Lim, MD
- Speakers: Jean Krutmann, MD & Anthony Brown, PhD
Sunday, March 29, 2026 | Theater 2 |
|---|
11:15 a.m. - 12:00 p.m.
Presented by: Thermo Fisher Scientific
Novel Discovery to Clinical Dermatology: Tregs in Inflammatory Skin Diseases
This session examines Nobel Prize-winning discoveries in regulatory T-cell biology and their clinical impact in atopic dermatitis and alopecia areata, translating immune tolerance science into practical dermatologic care.
12:45 p.m. - 1:30 p.m.
Presented by: Sanofi
Illuminating the Inflammatory Prequel in Atopic Dermatitis
Explore drivers of atopic dermatitis, including an inflammatory prequel involving OX40/OX40L signaling, and the importance of non-T-cell depletion when targeting inflammation.
